Hypermethylation of CpGs 1 and 4, and a high average SLC6A4 methylation value, predicted poor long-term stroke outcomes (composite CCVEs and recurrent stroke), especially in patients who experienced SI within 2 weeks of stroke. Here, SLC6A4 is linked to stroke disorder.